Jeannine Sheehan

Jeannine Sheehan, listed as senior executive, appears in our data through filings on InfuSystem Holdings, Inc shares, published by SEC (Form 4). The record holds 23 filings, for trades running from 6 February 2020 to 20 May 2022.

The open-market side counts 7 purchases for €2,637 alongside 3 sales for €239k. The totals do not cover 3 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 9 share grants and 4 option exercises. 2022 to date brings no purchases and 2 sales.

The median purchase comes to €587. 4 out of 4 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. For 4 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 100% of cases, with a median move of +29.1%. These figures describe past trades and do not predict future prices.

The record was last updated on 23 May 2022 with a share grant (€36k) in InfuSystem Holdings, Inc. The most recent open-market purchase was published on 21 May 2021, 1,998 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.